| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 4, 2019
DUBLIN - March 4, 2019 - Medtronic plc (NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering of €500,000,000...
-
Mar 4, 2019
DUBLIN - March 4, 2019 - Medtronic plc (the "Company") (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and...
-
Mar 1, 2019
DUBLIN - March 1, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 39th Annual Cowen and Company Healthcare Conference on...
-
Feb 27, 2019Medtronic Expands Pain Portfolio with Minimally Invasive Therapy to Support Patients Throughout the Care Continuum
DUBLIN - February 27, 2019 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio...
-
Feb 20, 2019
DUBLIN - February 20, 2019 - Medtronic plc (the "Company") (NYSE: MDT) today announced the commencement of a cash tender offer by its indirectly wholly owned subsidiaries, Medtronic, Inc....
-
Feb 20, 2019Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference...
-
Feb 14, 2019Value-Based Health Care Partnership Will Target Acute Conditions and Chronic Diseases in South Carolina
DUBLIN and CHARLESTON, S.C. - February 14, 2019 - Medtronic plc (NYSE:MDT) and the Medical University of South Carolina (MUSC) today announced a five-year value-based health care partnership...
-
Jan 30, 2019New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury
DUBLIN and SAN DIEGO - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of the Valiant(TM) Captivia(TM) thoracic stent...
-
Jan 17, 2019Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids
DUBLIN - January 17, 2019 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the...
-
Dec 28, 2018
DUBLIN - December 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San...
-
Dec 7, 2018
DUBLIN - December 7, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent...
-
Dec 3, 2018Study Will Evaluate Simultaneous Use of Radiofrequency and Cryo Surgical Ablation Devices in Cardiac Surgery Patients with Atrial Fibrillation
DUBLIN - December 3, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient treated in the TERMINATE AF trial, a multi-center study evaluating two surgical ablation devices - the...
-
Nov 16, 2018Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies
DUBLIN and NEW YORK - November 16, 2018 - Medtronic plc (NYSE:MDT) today announced new data on the Heli-FX(TM) EndoAnchor(TM) system, which demonstrated durability, safety and efficacy in patients...
-
Nov 8, 2018FDA-Approved Study Furthers Medtronic Commitment to Generate Meaningful Clinical Evidence for Use of Renal Denervation to Treat Uncontrolled Hypertension
DUBLIN - November 8, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin a clinical trial to evaluate the Symplicity Spyral(TM) renal...
-
Oct 24, 2018
(GLOBE NEWSWIRE via COMTEX) --myPTM Allows Patients to Personalize Their Treatment by Delivering On-Demand Boluses, or Drug Doses, Within Therapeutic Limits Set by Their Physician DUBLIN - October...
-
Oct 16, 2018
(GLOBE NEWSWIRE via COMTEX) --For Use with SynchroMed(TM) II Intrathecal Drug Delivery System, the Control WorkflowAims to Effectively Address Chronic Pain Without the Use of Oral Opioids DUBLIN -...
-
Sep 25, 2018
GLOBE NEWSWIRE via COMTEX) --System is Fully Integrated with Medtronic's Market-Leading Imaging and Navigation Technology to Transform Posterior Cervical Spine Surgery DUBLIN and LOS ANGELES -...
-
Sep 24, 2018
(GLOBE NEWSWIRE via COMTEX) --TCT18: New Five-Year Data with CoreValve TAVR System Suggests Durability Over Time, While Complete Results from the SURTAVI Trial Show Benefits of TAVR in...
-
Sep 21, 2018TCT18: BIONYX Study Shows Strong Performance with Durable Polymer Resolute Onyx DES in Head-to-Head Comparison with Biodegradable Polymer DES
DUBLIN and SAN DIEGO - September 22, 2018 - Investigators today unveiled new clinical data from the physician-initiated BIONYX study, representing the first all-comers analysis in nearly 2,500...
-
Sep 21, 2018Clinical Evidence Shared at TCT and CIRSE Reaffirm IN.PACT(TM) Admiral(TM) Drug-Coated Balloon as a Primary Therapy to Treat Complex, Real-World Patient Populations
SAN DIEGO and LISBON, Portugal - September 22, 2018 - Medtronic plc (NYSE:MDT) data announced today continue to reinforce the safety, durability, and consistency of the IN.PACT(TM) Admiral(TM)...
-
Sep 20, 2018Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions
DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of...
-
Sep 17, 2018
(GLOBE NEWSWIRE via COMTEX) --Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality DUBLIN - September 17, 2018 - Medtronic plc (NYSE:MDT) today...
-
Sep 4, 2018
(GLOBE NEWSWIRE via COMTEX) --DUBLIN - September 4, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual...
-
Aug 28, 2018
(GLOBE NEWSWIRE via COMTEX) --DUBLIN - August 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 13th Annual Wells Fargo...
-
Aug 24, 2018
GLOBE NEWSWIRE via COMTEX) --DUBLIN - August 24, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 second quarter cash dividend of $0.50 per ordinary...
-
Jul 31, 2018
(GLOBE NEWSWIRE via COMTEX) --Twenty Runners Representing 13 Countries to Participate in the Medtronic Twin Cities Marathon Weekend This October DUBLIN - July 31, 2018 - This October, 20 runners...
-
Jun 21, 2018(GLOBE NEWSWIRE via COMTEX) --41st Consecutive Year of Dividend Increases
DUBLIN - June 22, 2018 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 9 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.50 per ordinary...
-
Jun 21, 2018Real-World Experience Data on Sugar.IQ App Use Presented at the 78th Scientific Sessions of the American Diabetes Association
DUBLIN AND CAMBRIDGE - June 22, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson...
-
Jun 19, 2018(GLOBE NEWSWIRE via COMTEX) --Medtronic Will Host a Webcast of Its Diabetes Group Analyst and Investor Briefing on Monday, June 25 from 9 - 10 a.m. EDT
DUBLIN - June 19, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 78th Scientific Sessions...
-
May 29, 2018
DUBLIN - May 29, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on...
-
May 24, 2018Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation
DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that...
-
May 24, 2018Q4 Revenue of $8.1 Billion Grew 2.9% Reported and 6.5% Organic
DUBLIN - May 24, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2018, which ended April 27, 2018. The company reported fourth quarter...
-
May 23, 2018Late-Breaking SPYRAL HTN-ON MED Study at EuroPCR Indicates RDN Lowers Blood Pressure in Hypertensive Patients in Presence of BP Medication
DUBLIN and PARIS - May 23, 2018 - Medtronic plc (NYSE:MDT) today announced first-ever-data from the SPYRAL HTN-ON MED Study. Initial study results found statistically significant and clinically...
-
May 15, 2018Real-World Data on AdaptivCRT(TM) Algorithm Presented at Heart Rhythm 2018
DUBLIN - May 15, 2018 - Medtronic plc (NYSE: MDT) announced study results showing its exclusive AdaptivCRT(TM) algorithm is associated with improved patient survival. The data were recently...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Shows Potential for More Patients to Benefit from World's Smallest Pacemaker
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced new clinical study results demonstrating that an investigational algorithm, utilizing the accelerometer signal in the...
-
May 11, 2018Late-Breaking Presentation at Heart Rhythm 2018 Highlights Investigational Experience with ICD Lead Placed Under Sternum, Outside the Heart and Veins
DUBLIN and BOSTON - May 11, 2018 - Medtronic plc (NYSE:MDT) today announced results from a research study demonstrating the feasibility of a novel approach to delivering pacing and defibrillation...
-
May 9, 2018Results Presented at Heart Rhythm 2018 Also Show Leadless Pacemaker is Safe Option for Patients with Past Device Infection
DUBLIN and BOSTON - May 9, 2018 - Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing...
-
May 7, 2018
DUBLIN - May 7, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role,...
-
May 2, 2018Integrated Technologies Allow a Fully Navigated Procedure with Fewer Surgical Steps
DUBLIN and NEW ORLEANS - May 2, 2018 - Medtronic plc (NYSE: MDT) today announced the advanced SynergyTLIFSM workflow - a procedural solution for spine surgery that combines innovative technologies...
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'
-
May 1, 2018Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery ImplantsTechnology Allows for Creation of More Intricate Implant Designs and Surface Textures
DUBLIN and NEW ORLEANS - May 1, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and...
-
Apr 26, 2018
DUBLIN and SAN DIEGO - April 26, 2018 - Medtronic plc (NYSE: MDT) today announced two-year outcomes for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study....
-
Apr 9, 2018Pivotal Trial Now Underway to Study Effect of Investigational Procedure in Patients with High Blood Pressure
DUBLIN - April 9, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the...
-
Mar 20, 2018Positive Data on Exclusive AdaptivCRT(TM) Feature Unveiled at EHRA Scientific Sessions 2018
DUBLIN and BARCELONA, Spain - March 20, 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial...
-
Mar 13, 2018
DUBLIN - March 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday,...
-
Mar 12, 2018Medtronic Seeks Up to 20 Runners Who Benefit from Medical Technology
DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that applications are now being accepted for the 2018 Medtronic Global Champions team....
-
Mar 10, 2018Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time
DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic Valve...
-
Mar 9, 2018
DUBLIN - March 9, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 fourth quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...
-
Mar 8, 2018
DUBLIN - March 8, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 38th Annual Cowen and Company Healthcare Conference on...
-
Feb 26, 2018FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute...